Department of Medical, Oral and Biotechnological Sciences, University of Chieti-Pescara, Chieti, Italy.
Institute of Dentistry and Maxillofacial, Surgery, Fondazione Policlinico Universitario A. Gemelli IRCCS, Catholic University of the Sacred Heart, Rome, Italy.
J Clin Periodontol. 2019 Mar;46(3):382-395. doi: 10.1111/jcpe.13080.
This systematic review of randomized controlled trials (RCTs) aims to answer to the following question: "In patients undergoing dental implant placement, which is the best antibiotic prophylaxis protocol to prevent early failures?"
The MEDLINE, SCOPUS, CENTRAL and Web of Knowledge electronic databases were searched in duplicate for RCTs up to July 2017. Additional relevant literature was identified through (i) handsearching on both relevant journals and reference lists, and (ii) searching in databases for grey literature. A network meta-analysis (NMA) was conducted, and the probability that each protocol is the "Best" was estimated.
Nine RCTs were included, with a total of 1,693 participants. Due to the few events reported, it was not possible to conduct a NMA for adverse events, therefore it was conducted only for implant failures (IF). The protocol with the highest probability (32.5%) of being the "Best" one to prevent IF was the single dose of 3 g of amoxicillin administered 1 hr pre-operatively. Even if the single pre-operative dose of 2 g of amoxicillin is the most used, it achieved only a probability of 0.2% to be the "Best" one.
Basing on the available RCTs, the use of antibiotic prophylaxis is protective against early implant failures. Whenever an antibiotic prophylaxis is needed, there is still insufficient evidence to confidently recommend a specific dosage. The use of post-operative courses does not seem however to be justified by the available literature. Prospero registration number: CRD42015029708.
本系统评价旨在回答以下问题:“在接受牙种植体植入的患者中,哪种抗生素预防方案能最佳预防早期失败?”
对截至 2017 年 7 月的 MEDLINE、SCOPUS、CENTRAL 和 Web of Knowledge 电子数据库进行了重复检索,以寻找随机对照试验(RCT)。通过(i)在手头期刊和参考文献列表中进行手工搜索,以及(ii)在数据库中搜索灰色文献,确定了其他相关文献。进行了网络荟萃分析(NMA),并估计了每种方案成为“最佳”的概率。
纳入了 9 项 RCT,共计 1693 名参与者。由于报道的事件较少,无法对不良反应进行 NMA,因此仅对种植体失败(IF)进行了 NMA。预防 IF 的“最佳”方案是术前 1 小时给予单次 3g 阿莫西林,其概率最高(32.5%)。尽管单次术前给予 2g 阿莫西林的方案应用最广,但成为“最佳”方案的概率仅为 0.2%。
根据现有 RCT,抗生素预防可预防早期种植体失败。无论何时需要抗生素预防,都没有足够的证据能自信地推荐特定剂量。现有文献并未支持使用术后疗程。注册号:CRD42015029708。